SEARCH

SEARCH BY CITATION

References

  • International Diabetes Federation. 2011. Diabetes Atlas. 5th ed. Belgium: IDF.
  • Yoon, K.H., J.H. Lee, J.W. Kim, et al. 2006. Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 16811688.
  • Chan, J.C., V. Malik, W. Jia, et al. 2009. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301: 21292140.
  • Ramachandran, A., R.C. Ma & C. Snehalatha. 2010. Diabetes in Asia. Lancet 375: 408418.
  • Ma, R.C. & P.C. Tong. 2010. “Epidemiology of type 2 diabetes.” In: Textbook of Diabetes 4th ed. R. Holt, B. Goldstein, A. Flyvbjerg, C.S. Cockram, Eds.: 4568. New York: Wiley-Blackwell.
  • Yang, W., J. Lu, J. Weng, et al. 2010. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 362: 10901101.
  • Li, H., B. Oldenburg, C. Chamberlain, et al. 2012. Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: a systematic review. Diabetes Res. Clin. Pract. 98: 226235.
  • Wong, K.C. & Z. Wang. 2006. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res. Clin. Pract. 73: 126134.
  • Centers for Disease Control and Prevention. 2011. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.
  • Dowse, G.K., P.Z. Zimmet & H. King. 1991. Relationship between prevalence of impaired glucose tolerance and NIDDM in a population. Diabetes Care 14: 968974.
  • Chen, L., D.J. Magliano & P.Z. Zimmet. 2012. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat. Rev. Endocrinol. 8: 228236.
  • The DECODA Study Group. 2003. Age and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 26: 17701780.
  • 2003. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26: 6169.
  • Jiang, Y.D., C.H. Chang, T.Y. Tai, et al. 2012. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000–2009 Nationwide Health Insurance database. J. Formos. Med. Assoc. 111: 599604.
  • 2012. Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl. 1): S64S71.
  • World Health Organization, International Diabetes Federation. 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Geneva, Switzerland: World Health Organization International Diabetes Federation.
  • Ko, G.T.C., J.C.N. Chan, J. Woo & C.S. Cockram. 1998. The use of the 1997 American Diabetes Association Diagnostic criteria in a Hong Kong Chinese population. Diabetes Care 21: 20942097.
  • Qiao, Q., T. Nakagami, J. Tuomilehto, et al. 2000. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 43: 14701475.
  • World Health Organization. 2011. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. In: WHO, ed.: 25. Geneva, Switzerland: World Health Organization.
  • Dagogo-Jack, S. 2010. Pitfalls in the use of HbA(1)(c) as a diagnostic test: the ethnic conundrum. Nat. Rev. Endocrinol. 6: 589593.
  • Bennett, C.M., M. Guo & S.C. Dharmage. 2007. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet. Med. 24: 333343.
  • Anand, S.S., F. Razak, V. Vuksan, et al. 2003. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 26: 290296.
  • Herman, W.H., Y. Ma, G. Uwaifo, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30: 24532457.
  • Bao, Y., X. Ma, H. Li, et al. 2010. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. Br. Med. J. 340: c2249.
  • Ko, G.T.C., J.C.N. Chan, V.T.F. Yeung, et al. 1998. The combined use of a fasting plasma glucose concentration and glycated hemoglobin or fructosamine predicts the likelihood of having diabetes mellitus in high risk subjects. Diabetes Care 21: 12211225.
  • Jia, W.P., C. Pang, L. Chen, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007; 50: 286292.
  • Ko, G.T.C., J.C.N. Chan, J. Woo & C.S. Cockram. 1999. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple arthropometric indexes in Hong Kong Chinese. Int. J. Obes. 23: 11361142.
  • McKeigue, P.M., B. Shah & M.G. Marmot. 1991. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337: 382386.
  • Deurenberg, P., M. Yap & W.A. van Staveren. 1998. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int. J. Obes. Relat. Metab. Disord. 22: 11641171.
  • He, M., K.C. Tan, E.T. Li & A.W. Kung. 2001. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int. J. Obes. Related Metab. Dis. 25: 748752.
  • WHO/IASO/IOTF. 2000. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Western Pacific Region, Hong Kong: World Health Organsiation.
  • WHO Expert Consultation. 2004. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157163.
  • Boffetta, P., D. McLerran, Y. Chen, et al. 2011. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One 6: e19930.
  • Koh-Banerjee, P., Y. Wang, F.B. Hu, et al. 2004. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am. J. Epidemiol. 159: 11501159.
  • Wang, Y., E.B. Rimm, M.J. Stampfer, et al. 2005. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 81: 555563.
  • Huxley, R., W.P. James, F. Barzi, et al. 2008. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes. Rev. 9(Suppl. 1): 5361.
  • Nyamdorj, R., J. Pitkaniemi, J. Tuomilehto, et al. 2010. Ethnic comparison of the association of undiagnosed diabetes with obesity. Int. J. Obes. 34: 332339.
  • Stevens, J., K.P. Truesdale, E.G. Katz & J. Cai. 2008. Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People's Republic of China Study and the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 167: 13651374.
  • Chiu, M., P.C. Austin, D.G. Manuel, et al. 2011. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 34: 17411748.
  • Ma, Y., J.R. Hebert, J.E. Manson, et al. 2012. Determinants of racial/ethnic disparities in incidence of diabetes in postmenopausal women in the U.S.: the Women's Health Initiative 1993–2009. Diabetes Care 35: 22262234.
  • Deurenberg, P., M. Deurenbery-Yap & S. Guricci. 2002. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes. Rev. 3: 141146.
  • Fujimoto, W.Y., E.J. Boyko, T. Hayashi, et al. 2012. Risk factors for type 2 diabetes: lessons learned from Japanese Americans in Seattle. J. Diabet. Investig. 3: 212224.
  • Fox, K.A., J.P. Despres, A.J. Richard, et al. 2009. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur. Heart J. 30: 30553063.
  • Bergstrom, R.W., L.L. Newell-Morris, D.L. Leonetti, et al. 1990. Association of elevated C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39: 104111.
  • Boyko, E.J., W.Y. Fujimoto, D.L. Leonetti & L. Newell-Morris. 2000. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23: 465471.
  • Hayashi, T., E.J. Boyko, D.L. Leonetti, et al. 2003. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 26: 650655.
  • Lear, S.A., K.H. Humphries, S. Kohli, et al. 2007. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am. J. Clin. Nutr. 86: 353359.
  • Unger, R.H. 1996. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes 44: 863870.
  • Fraser, A., R. Harris, N. Sattar, et al. 2009. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32: 741750.
  • Wong, V.W. 2012. Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics. Diabet. Med. 29: 366371.
  • Taylor, R. 2008. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 51: 17811789.
  • Kahn, S.E. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46: 319.
  • Abdul-Ghani, M.A., D. Tripathy & R.A. DeFronzo. 2006. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 11301139.
  • Chiu, K.C., P. Cohan, N.P. Lee & L.M. Chuang. 2000. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23: 13531358.
  • Hayashi, T., E.J. Boyko, M.J. McNeely, et al. 2008. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 57: 12691275.
  • Tanaka, Y., Y. Atsumi, K. Matsuoka, et al. 2000. Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care 23: 710712.
  • Kawamori, R. 2002. Diabetes trends in Japan. Diabetes Metab. Res. Rev. 18(Suppl. 3): S9S13.
  • Goodpaster, B.H., S. Krishnaswami, H. Resnick, et al. 2003. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26: 372379.
  • Chiu, K.C., L.M. Chuang & C. Yoon. 2001. Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucose-tolerant and normotensive subjects. J. Clin. Endocrinol. Metab. 86: 16201625.
  • Ahima, R.S. & S.F. Jeffery. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11: 327332.
  • Hsu, W.C., E. Okeke, S. Cheung, et al. 2011. A cross-sectional characterization of insulin resistance by phenotype and insulin clamp in East Asian Americans with type 1 and type 2 diabetes. PLoS One 6: e28311.
  • Tso, A.W., A. Xu, P.C. Sham, et al. 2007. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30: 26672672.
  • Cheung, B.M., N.M. Wat, Y.B. Man, et al. 2007. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 30: 14301436.
  • Wallace, D.C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39: 359407.
  • Abdul-Ghani, M.A. & R.A. DeFronzo. 2008. Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr. Diab. Rep. 8: 173178.
  • Ng, M.C.Y., S.C. Lee, G.T.C. Ko, et al. 2001. Familial early onset type 2 diabetes in Chinese: the more significant roles of obesity and genetics than autoimmunity. Diabetes Care 24: 667671.
  • Park, K.S., J.C. Chan, L.M. Chuang, et al. 2008. A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia 51: 602608.
  • Wallace, D.C. 2010. Bioenergetics and the epigenome: interface between the environment and genes in common diseases. Dev. Disabil. Res. Rev. 16: 114119.
  • Chan, J.C., W. So, R.C. Ma, et al. 2011. The complexity of vascular and non-vascular complications of diabetes: the Hong Kong Diabetes Registry. Curr. Cardiovasc. Risk Rep. 5: 230239.
  • Urakami, T., S. Kubota, Y. Nitadori, et al. 2005. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28: 18761881.
  • Wei, J.N., F.C. Sung, C.C. Lin, et al. 2003. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 290: 13451350.
  • Huen, K.F., L.C.K. Low, P.T. Cheung, et al. 2009. An update on the epidemiology of childhood diabetes in Hong Kong. HK J. Paediatr. 14: 252259.
  • Dabelea, D., R.A. Bell, R.B. D'Agostino, Jr., et al. 2007. Incidence of diabetes in youth in the United States. JAMA 297: 27162724.
  • Chuang, L.M., S. Soegondo, P. Soewondo, et al. 2006. Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res. Clin. Pract. 71: 146155.
  • Gu, D., K. Reynolds, X. Duan, et al. 2003. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46: 11901198.
  • Thai, A.C., V. Mohan, B.A. Khalid, et al. 2008. Islet autoimmunity status in Asians with young-onset diabetes (12–40 years): association with clinical characteristics, beta cell function and cardio-metabolic risk factors. Diabetes Res. Clin. Pract. 80: 224230.
  • Ko, G.T.C., J.C.N. Chan, V.T.F. Yeung, et al. 1998. Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Ann. Clin. Biochem. 35: 761767.
  • Annis, A.M., M.S. Caulder, M.L. Cook & D. Duquette. 2005. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999–2002. Prev. Chronic. Dis. 2: A19.
  • Yang, Q., T. Liu, R. Valdez, et al. 2010. Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am. J. Epidemiol. 171: 10791089.
  • Ng, M.C., S.C. Lee, G.T. Ko, et al. 2001. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care 24: 663671.
  • Chung, J.O., D.H. Cho, D.J. Chung & M.Y. Chung. 2010. Plasma C-peptide level is inversely associated with family history of type 2 diabetes in Korean type 2 diabetic patients. Endocr. J. 57: 931938.
  • Yoon, K.H., S.H. Ko, J.H. Cho, et al. 2003. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J. Clin. Endocrinol. Metab. 88: 23002308.
  • Chan, W.B., P.C.Y. Tong, C.C. Chow, et al. 2004. The associations of body mass index, C peptide and metabolic status in Chinese type 2 diabetic patients. Diabet. Med. 21: 349353.
  • Fujimoto, W.Y., R.W. Bergstrom, E.J. Boyko, et al. 2000. Type 2 diabetes and the metabolic syndrome in Japanese Americans. Diabetes Res. Clin. Pract. 50(Suppl. 2): S73S76.
  • McCarthy, M.I. 2010. Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363: 23392350.
  • Voight, B.F., L.J. Scott, V. Steinthorsdottir, et al. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42: 579589.
  • Cho, Y.S., C.H. Chen, C. Hu, et al. 2011. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nat. Genet. 44: 6772.
  • Morris, A.P., B.F. Voight, T.M. Teslovich, et al. 2012. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44: 981990.
  • Li, J.K., M.C. Ng, W.Y. So, et al. 2006. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 22: 4652.
  • Kuroe, A., M. Fukushima, M. Usami, et al. 2003. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res. Clin. Pract. 59: 7177.
  • Nishi, Y., M. Fukushima, H. Suzuki, et al. 2005. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Res. Clin. Pract. 70: 4652.
  • Takeuchi, M., K. Okamoto, T. Takagi & H. Ishii. 2008. Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: a systematic review and meta-analysis focusing on fasting serum insulin. Diabetes Res. Clin. Pract. 81: 370376.
  • Taniguchi, A., M. Fukushima, M. Sakai, et al. 2000. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care 23: 127128.
  • Fukushima, M., M. Usami, M. Ikeda, et al. 2004. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53: 831835.
  • Utzschneider, K.M., R.L. Prigeon, M.V. Faulenbach, et al. 2009. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32: 335341.
  • Abdul-Ghani, M.A., K. Williams, R.A. DeFronzo & M. Stern. 2007. What is the best predictor of future type 2 diabetes? Diabetes Care 30: 15441548.
  • Kim, S.K., J.H. Kim, J.Y. Park, et al. 2011. Indexes of beta-cell function from the oral glucose tolerance test can modestly predict pancreatic beta-cell area in Korean. Diabetes Res. Clin. Pract. 93: 220227.
  • Torrens, J.I., J. Skurnick, A.L. Davidow, et al. 2004. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27: 354361.
  • Kahn, S.E., C.B. Verchere, S. Andrikopoulos, et al. 1998. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes 47: 640645.
  • Haataja, L., T. Gurlo, C.J. Huang & P.C. Butler. 2008. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 29: 303316.
  • Butler, A.E., J. Janson, S. Bonner-Weir, et al. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102110.
  • Zhao, H.L., F.M.M. Lai, P.C.Y. Tong, et al. 2003. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52: 27592766.
  • Turner, R.C., I. Stratton, V. Horton, et al. 1997. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350: 12881293.
  • Park, Y., H. Lee, C.S. Koh, et al. 1996. The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19: 241245.
  • Tsuruoka, A., I. Matsuba, T. Toyota, et al. 1995. Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res. Clin. Pract. 28: 191199.
  • Zinman, B., S.E. Kahn, S.M. Haffner, et al. 2004. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53: 31933200.
  • Roh, M.O., C.H. Jung, B.Y. Kim, et al. 2010. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea. Acta Diabetol. Oct. 16; PMID: 20953640.
  • Ng, M.C., K.S. Park, B. Oh, et al. 2008. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57: 22262233.
  • Yokoi, N., M. Kanamori, Y. Horikawa, et al. 2006. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes 55: 23792386.
  • Yasuda, K., K. Miyake, Y. Horikawa, et al. 2008. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40: 10921097.
  • Tsai, F.J., C.F. Yang, C.C. Chen, et al. 2010. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 6: e1000847.
  • Barker, D.J., P.D. Gluckman, K.M. Godfrey, et al. 1993. Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938941.
  • Gluckman, P.D., M.A. Hanson, C. Cooper & K.L. Thornburg. 2008. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359: 6173.
  • Gluckman, P.D., M.A. Hanson, T. Buklijas, et al. 2009. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 5: 401408.
  • Godfrey, K.M., K.A. Lillycrop, G.C. Burdge, et al. 2007. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr. Res. 61: 5R10R.
  • Li, Y., Y. He, L. Qi, et al. 2010. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes 59: 24002406.
  • Ma, R.C. & J.C. Chan. 2009. Pregnancy and diabetes scenario around the world: China. Int. J. Gynaecol. Obstet. 104(Suppl. 1): S42S45.
  • Lawrence, J.M., R. Contreras, W. Chen & D.A. Sacks. 2008. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31: 899904.
  • Pettitt, D.J., K.A. Aleck, H.R. Baird, et al. 1988. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 37: 622628.
  • Dabelea, D., R.L. Hanson, R.S. Lindsay, et al. 2000. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49: 22082211.
  • Sobngwi, E., P. Boudou, F. Mauvais-Jarvis, et al. 2003. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361: 18611865.
  • Dabelea, D. & T. Crume. 2011. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60: 18491855.
  • Pettitt, D.J., J.M. Lawrence, J. Beyer, et al. 2008. Association between maternal diabetes in utero and age at offspring's diagnosis of type 2 diabetes. Diabetes Care 31: 21262130.
  • Pavkov, M.E., R.L. Hanson, W.C. Knowler, et al. 2010. Effect of intrauterine diabetes exposure on the incidence of end-stage renal disease in young adults with type 2 diabetes. Diabetes Care 33: 23962398.
  • Ferrara, A. 2007. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30(Suppl. 2): S141S146.
  • Zhang, F., L. Dong, C.P. Zhang, et al. 2011. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet. Med. 28: 652657.
  • Hedderson, M., S. Ehrlich, S. Sridhar, et al. 2012. Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care 35: 14921498.
  • Kim, C., K.M. Newton & R.H. Knopp. 2002. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 18621868.
  • HAPO Study Cooperative Research Group. 2009. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58: 453459.
  • Boney, C.M., A. Verma, R. Tucker & B.R. Vohr. 2005. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115: e290e296.
  • Tam, W.H., R.C. Ma, X. Yang, et al. 2008. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics 122: 12291234.
  • Tam, W.H., R.C. Ma, X. Yang, et al. 2010. Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up study. Diabetes Care 33: 13821384.
  • Asia Pacific Cohort Studies Collaboration. 2007. The burden of overweight and obesity in the Asia-Pacific region. Obes. Rev. 8: 191196.
  • Gu, D., K. Reynolds, X. Wu, et al. 2005. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 13981405.
  • Gu, D., A. Gupta, P. Muntner, et al. 2005. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 112: 658665.
  • He, J., D. Gu, X. Wu, et al. 2005. Major causes of death among men and women in China. N. Engl. J. Med. 353: 11241134.
  • Popkin, B.M., S. Horton, S. Kim, et al. 2001. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr. Rev. 59: 379390.
  • Du, S., B. Lu, F. Zhai & B.M. Popkin. 2002. A new stage of the nutrition transition in China. Public Health Nutr. 5: 169174.
  • Foster-Powell, K., S.H. Holt & J.C. Brand-Miller. 2002. International table of glycemic index and glycemic load values: 2002. Am. J. Clin. Nutr. 76: 556.
  • Villegas, R., S. Liu, Y.T. Gao, et al. 2007. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch. Intern. Med. 167: 23102316.
  • Nanri, A., T. Mizoue, M. Noda, et al. 2010. Rice intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am. J. Clin. Nutr. 92: 14681477.
  • Hu, E.A., A. Pan, V. Malik & Q. Sun. 2012. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. Br. Med. J. 344: e1454.
  • Henry, C.J., H.J. Lightowler, K. Newens, et al. 2008. Glycaemic index of common foods tested in the UK and India. Br. J. Nutr. 99:840845.
  • Nakanishi, N., K. Nakamura, Y. Matsuo, et al. 2000. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann. Intern. Med. 133: 183191.
  • Chen, Z., Y.S. Shin & R. Beaglehole. 2012. Tobacco control in China: small steps towards a giant leap. Lancet 379: 779780.
  • Lim, S., Y.M. Cho, K.S. Park & H.K. Lee 2010. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann. N.Y. Acad. Sci. 1201: 166176.
  • Spiegel, K., E. Tasali, R. Leproult & Van E. Cauter. 2009. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat. Rev. Endocrinol. 5: 253261.
  • Olds, T., S. Blunden, J. Petkov & F. Forchino. 2010. The relationships between sex, age, geography and time in bed in adolescents: a meta-analysis of data from 23 countries. Sleep. Med. Rev. 14: 371378.
  • Shaw, J.E., N.M. Punjabi, J.P. Wilding, et al. 2008. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res. Clin. Pract. 81: 212.
  • Kim, J., H.M. Kim, K.M. Kim & D.J. Kim. 2009. The association of sleep duration and type 2 diabetes in Korean male adults with abdominal obesity: the Korean National Health and Nutrition Examination Survey. 2005. Diabetes Res. Clin. Pract. 86: e34e36.
  • Kachi, Y., K. Ohwaki & E. Yano. 2012. Association of sleep duration with untreated diabetes in Japanese men. Sleep. Med. 13: 307309.
  • Ko, G.T., J.C. Chan, A.W. Chan, et al. 2007. Association between sleeping hours, working hours and obesity in Hong Kong Chinese: the ‘better health for better Hong Kong' health promotion campaign. Int. J. Obes. 31: 254260.
  • Kong, A.P., Y.K. Wing, K.C. Choi, et al. 2011. Associations of sleep duration with obesity and serum lipid profile in children and adolescents. Sleep. Med. 12: 659665.
  • Jeon, C.Y., M.N. Haan, C. Cheng, et al. 2012. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 35: 520525.
  • Ojetti, V., R. Pellicano, S. Fagoonee, et al. 2010. Helicobacter pylori infection and diabetes. Minerva. Med. 101: 115119.
  • Tian, T., L.Q. Zhang, X.H. Ma, et al. 2012. Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis. Exp. Clin. Endocrinol. Diabetes 120: 217223.
  • So, W.Y., P.C. Tong, G.T. Ko, et al. 2009. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res. Clin. Pract. 86: 8995.
  • Lao, T.T., K.Y. Tse, L.Y. Chan, et al. 2003. HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 26: 30113016.
  • Cheng, A.Y., A.P. Kong, V.W. Wong, et al. 2006. Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia 49: 17771784.
  • Cockram, C.S. & N. Lee. 2010. “Diabetes and Infection.” In: Textbook of Diabetes. 4th Edition ed. R.I. Holt, C.S. Cockram, A. Flyvberg, B.J. Goldstein, Eds.: 835858. Chichester, West Sussex: John Wiley & Sons, Ltd.
  • Lee, E.T., M. Lu, P.H. Bennett & H. Keen. 2001. Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl. 2): S78S81.
  • Lee, E.T., H. Keen, P.H. Bennett, et al. 2001. Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 44(Suppl. 2): S3S13.
  • Chi, Z.S., E.T. Lee, M. Lu, H. Keen & P.H. Bennett. 2001. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl. 2): S82S86.
  • McGill, M.J., R. Donnelly, L. Molyneaux & D.K. Yue. 1996. Ethnic differences in the prevalence of hypertension and proteinuria in NIDDM. Diabetes Res. Clin. Pract. 33: 173179.
  • Wu, A.Y., N.C. Kong, F.A. de Leon, et al. 2005. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48: 1726.
  • Parving, H.H., R. Osterby & E. Ritz. 2000. “Diabetic Nephropathy.” In: The Kidney. B.M. Brenner, Ed.: 17311773. Philadelphia: WB Saunders.
  • Adler, A.I., R.J. Stevens, S.E. Manley, et al. 2003. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63: 225232.
  • Parving, H.H., J.B. Lewis, M. Ravid, et al. 2006. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 69: 20572063.
  • Kenealy, T., C.R. Elley, J.F. Collins, et al. 2012. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol. Dial. Transplant. 27: 18401846.
  • Young, B.A., W.J. Katon, M. Von Korff, et al. 2005. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J. Am. Soc. Nephrol. 16: 219228.
  • Luk, A.O., W.Y. So, R.C. Ma, et al. 2008. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31: 23572361.
  • Luk, A. & J.C. Chan. 2008. Diabetic nephropathy–what are the unmet needs? Diabetes Res. Clin. Pract. 82(Suppl. 1): S15S20.
  • Karter, A.J., A. Ferrara, J.Y. Liu, et al. 2002. Ethnic disparities in diabetic complications in an insured population. JAMA 287: 25192527.
  • Clarke, P.M., P. Glasziou, A. Patel, et al. 2010. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med. 7: e1000236.
  • Liu, J., Y. Hong, RB D'Agostino, Sr., et al. 2004. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291: 25912599.
  • Woodward, M., X. Zhang, F. Barzi, et al. 2003. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26: 360366.
  • Turner, R.C., H. Millns, H.A. Neil, et al. 1998. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br. Med. J. 316: 823828.
  • Yang, X., W.Y. So, A.P. Kong, et al. 2008. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am. J. Cardiol. 101: 596601.
  • Matsushita, K., M. van der Velde, B.C. Astor, et al. 2010. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 20732081.
  • So, W.Y., A.P. Kong, R.C. Ma, et al. 2006. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 29: 20462052.
  • Ma, R.C., W.Y. So, X. Yang, et al. 2008. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J. Am. Coll. Cardiol. 51: 20452050.
  • Gazzaruso, C., S.B. Solerte, A. Pujia, et al. 2008. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51: 20402044.
  • Sone, H., S. Tanaka, S. Iimuro, et al. 2012. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care 35: 11501157.
  • Seshasai, S.R., S. Kaptoge, A. Thompson, et al. 2011. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364: 829841.
  • Noto, H., T. Tsujimoto & M. Noda. 2012. Significantly increased risk of cancer in diabetes mellitus patients: a meta-analysis of epidemiological evidence in Asians and non-Asians. J. Diabetes Investig. 3: 2433.
  • Leung, C.C., T.H. Lam, W.M. Chan, et al. 2008. Diabetic control and risk of tuberculosis: a cohort study. Am. J. Epidemiol. 167:14861494.
  • Harries, A.D., M.B. Murray, C.Y. Jeon, et al. 2010. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop. Med. Int. Health 15: 659663.
  • Hu, D., P. Fu, J. Xie, et al. 2008. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res. Clin. Pract. 81: 250257.
  • Chan, J.C., J.J. Gagliardino, S.H. Baik, et al. 2009. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 32: 227233.
  • Fisher, E.B., J.C. Chan, H. Nan, et al. 2012. Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. J. Affect. Disord. 142(Suppl.): S56S66.
  • Inzucchi, S.E., R.M. Bergenstal, J.B. Buse, et al. 2012. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35: 13641379.
  • Rodbard, H.W., P.S. Jellinger, J.A. Davidson, et al. 2009. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr. Pract. 15: 540559.
  • IDF Clinical Guidelines Task Force. 2005. Global guideline for Type 2 Diabetes. Brussels: International Diabetes Federation.
  • Pan, C.Y. & H. Landen. 2007. Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China. Clin. Drug Investig. 27: 397405.
  • Kobayashi, M., K. Yamazaki, K. Hirao, et al. 2006. The status of diabetes control and antidiabetic drug therapy in Japan–a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). Diabetes Res. Clin. Pract. 73: 198204.
  • Tong, P.C., G.T. Ko, W.Y. So, et al. 2008. Use of anti-diabetic drugs and glycaemic control in type 2 diabetes-tThe Hong Kong Diabetes Registry. Diabetes Res. Clin. Pract. 82: 346352.
  • Yurgin, N., K. Secnik & M.J. Lage. 2007. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin. Ther. 29: 316325.
  • Li, Y., W. Xu, Z. Liao, et al. 2004. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27: 25972602.
  • Weng, J., Y. Li, W. Xu, et al. 2008. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371: 17531760.
  • Mohan, V., W. Yang, H.Y. Son, et al. 2009. Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea. Diabetes Res. Clin. Pract. 83: 106116.
  • Kikuchi, M., N. Abe, M. Kato, et al. 2009. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 83: 233240.
  • Pan, C., W. Yang, J.P. Barona, et al. 2008. Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabet. Med. 25: 435441.
  • Seino, Y., M.F. Rasmussen, T. Nishida & K. Kaku. 2010. Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes. Curr. Med. Res. Opin. 26: 10131022.
  • Mu, Y.M., A. Misra, J.M. Adam, et al. 2012. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res. Clin. Pract. 95: 179188.
  • Chan, J.C.N., N.M.S. Wat, W.Y. So, et al. 2004. RAAS blockade and renal disease in type 2 diabetic patients: an Asian perspective from the RENAAL Study. Diabetes Care 27: 874879.
  • Wang, W., C.W. Fu, C.Y. Pan, et al. 2009. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 12: 923929.
  • Cho, J.H., S.A. Chang, H.S. Kwon, et al. 2006. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care 29: 26252631.
  • Cho, J.H., H.C. Lee, D.J. Lim, et al. 2009. Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: as effective as an Internet-based glucose monitoring system. J. Telemed. Telecare 15: 7782.
  • Cho, J.H., H.S. Kwon, H.S. Kim, et al. 2011. Effects on diabetes management of a health-care provider mediated, remote coaching system via a PDA-type glucometer and the Internet. J. Telemed. Telecare 17: 365370.
  • Tricco, A.C., N.M. Ivers, J.M. Grimshaw, et al. 2012. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 379: 22522261.
  • Chan, J.C., W.Y. So, C.Y. Yeung, et al. 2009. Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study. Diabetes Care 32: 977982.
  • Chan, J., W. So, G. Ko, et al. 2009. The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in type 2 diabetes. Diabet. Med. 26: 693699.
  • Hanson, M.A., P.D. Gluckman, R.C. Ma, et al. 2012. Early life opportunities for prevention of diabetes in low and middle income countries. BMC Public Health 12: 1025.
  • Imamura, M., S. Maeda, T. Yamauchi, et al. 2012. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum. Mol. Genet. 21: 30423049.
  • Kong, A., V. Steinthorsdottir, G. Masson, et al. 2009. Parental origin of sequence variants associated with complex diseases. Nature 462: 868874.
  • Whiting, D., N. Unwin & G. Roglic. 2010. “Diabetes: equity and social determinants.” In: Equity, social determinants and public health programmes. E. Blas, A. Kurup, Eds.: 7794. Geneva, Switzerland: World Health Organization.
  • Wang, W.Q., T.P. Ip & K.S. Lam. 1998. Changing prevalence or retinopathy in newly diagnosed NIDDM patients in Hong Kong. Diabetes Res. Clin. Pract. 39: 185191.
  • Chang, C., F. Lu, Y.C. Yang, et al. 2000. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res. Clin. Pract. 50(Suppl. 2): S49S59.
  • Liu, D.P., L. Molyneaux, E. Chua, et al. 2002. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res. Clin. Pract. 56: 125131.
  • Wong, T.Y., N. Cheung, W.T. Tay, et al. 2008. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115: 18691875.
  • Wang, F.H., Y.B. Liang, F. Zhang, et al. 2009. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 116: 461467.
  • Kim, J.H., H.S. Kwon, Y.M. Park, et al. 2011. Prevalence and associated factors of diabetic retinopathy in rural Korea: the Chungju metabolic disease cohort study. J. Korean Med. Sci. 26: 10681073.
  • So, W.Y., J. Raboca, L. Sobrepena, et al. 2011. Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program. J. Diabetes 3: 109118.
  • Zhang, X., J.B. Saaddine, C.F. Chou, et al. 2010. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 304: 649656.
  • Wong, T.Y., F.M. Islam, R. Klein, et al. 2006. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest. Ophthalmol. Vis. Sci. 47: 23412350.
  • Kanaya, A.M., N. Adler, H.H. Moffet, et al. 2011. Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE). Diabetes Care 34: 930937.
  • Tao, M., M.A. McDowell, S.H. Saydah & M.S. Eberhardt. 2008. Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004. Diabetes Care 31: 9395.
  • Liu, Z., Fu C. Wang W. & Xu B. 2010. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients—a cross-sectional hospital based survey in urban China. Health Qual. Life Outcomes 8: 62.
  • Yang, X., W. So, G.T. Ko, et al. 2008. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. CMAJ 179: 427437.
  • Yang, X., W.Y. So, R.C. Ma, et al. 2008. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. Endocr. Relat. Cancer 15: 597607.
  • Jee, S.H., H. Ohrr, J.W. Sull, et al. 2005. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194202.